On November 17, 2021, AFAR Scientific Director Nir Barzilai, MD, Board Member Richard G. A. Faragher, PhD, and President James Kirkland, MD, PhD, presented during the one-day masterclass “Investing in the Age of Longevity 2021” in London. The program was part of UK Longevity Week, spearheaded by AFAR board member Jim Mellon.
In a morning session providing a foundation in the biology of aging and geroscience, Dr. Kirkland presented on senolytics and gerotherapeutics. Dr. Faragher presented on the intersection of the biology of aging and age-related disease and the promising impact of targeting both.
In an afternoon session focused on future momentum and translation into biotech opportunities, Dr. Barzilai presented on the AFAR-managed TAME Trial. Dr. Faragher summarizedthe insights from cross-sector, global leaders from a series of GeroFutures Think Tanks hosted by AFAR throughout 2021, including recommendations for investments in aging research today in order to encourage opportunities in biotech development and international collaboration.
Watch Dr. Faragher’s presentation, “The Geroscience Promise: How we age and what we can do about it,” here.
Watch Dr. Kirkland’s presentation, “Senolytics,” here.
Watch Dr. Barzilai’s presentation, “Targeting Aging with Metformin (TAME): A Concrete Plan to Pave the Way for Targeting Aging,” here.
Watch Dr. Faragher’s summary presentation, “AFAR GeroFutures Think Tank Reports Findings,” here. (Learn more about the findings from the GeroFuture Think Tank series and download the report here.)
***
Dr. Barzilai is a 1994 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, a 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, a 2010 Irving S. Wright Award of Distinction recipient, and the Director at the Institute for Aging Research and distinguished Professor at the Albert Einstein College of Medicine.
Dr. Faragher is past Chair of both the British Society for Research on Ageing and the International Association of Biomedical Gerontology and is Professor of Biogerontology at the University of Brighton.
Dr. Kirkland is AFAR’s Board President, a 2012 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award recipient, and a 2020 Irving S. Wright Award of Distinction recipient. He is also a distinguished Professor of Medicine and Physiology, as well as the Director at the Robert and Arlene Kogod Center on Aging at the Mayo Clinic College of Medicine.
